Technical, commercial and regulatory aspects of bioproducts scale-up

Marko Närhi; Katrina Nordström

Technical, commercial and regulatory aspects of bioproducts scale-up

Research output: Working paper › Professional

Original language	English
Publication status	Published - 2004
MoE publication type	D4 Published development or research report or study

Publication series

Name	Drug Information Association (DIA) Annual Meeting, Praha 8-13.3.2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 9 Industry, Innovation, and Infrastructure

Keywords

biopharmaceuticals, biomaterials, bioproducts, manufacturing, scale-up, regulatory

Cite this

@techreport{e0704ee3ba2e4602aa6d7ff1c407b59f,

title = "Technical, commercial and regulatory aspects of bioproducts scale-up",

keywords = "biopharmaceuticals, biomaterials, bioproducts, manufacturing, scale-up, regulatory, biopharmaceuticals, biomaterials, bioproducts, manufacturing, scale-up, regulatory, biopharmaceuticals, biomaterials, bioproducts, manufacturing, scale-up, regulatory",

author = "Marko N{\"a}rhi and Katrina Nordstr{\"o}m",

year = "2004",

language = "English",

series = "Drug Information Association (DIA) Annual Meeting, Praha 8-13.3.2004",

type = "WorkingPaper",

}

TY - UNPB

T1 - Technical, commercial and regulatory aspects of bioproducts scale-up

AU - Närhi, Marko

AU - Nordström, Katrina

PY - 2004

Y1 - 2004

KW - biopharmaceuticals, biomaterials, bioproducts, manufacturing, scale-up, regulatory

M3 - Working paper

T3 - Drug Information Association (DIA) Annual Meeting, Praha 8-13.3.2004

BT - Technical, commercial and regulatory aspects of bioproducts scale-up

ER -